Tous Actualités
Suivre
Abonner W.O.M. World of Medicine AG

W.O.M. World of Medicine AG

euro adhoc: W.O.M. World of Medicine AG
Financial Figures/Balance Sheet / WORLD OF MEDICINE: Due to preliminary numbers turnover and outcome of 3rd Quarter below plan/ Year end targets are at risk/ Cost reduction will be expanded/ Launch of important n

  Disclosure announcement transmitted by euro adhoc.
  The issuer is responsible for the content of this announcement.
21.10.2005
(Berlin, October 21st, 2005) Revenues of  medical device producer
WORLD OF MEDICINE turned out to be under plan in the 3rd quarter
2005, mainly caused by the postponed launch of an important new
product to the end of  the 3rd quarter as well as a difficult market
environment in Europe. Turnover in USA developed positively further
on. Compared to last year’s revenues for the first nine month of the
year, group revenues decreased by 13,1 % to 21,6 Mio. EUR.  The group
result was influenced mainly by severance payments, closing costs for
the facility in Gröbenzell and partial write offs in inventory and
mounted to -0,8 Mio. EUR for the nine month period. Due to the
unexpected development of revenues and the temporarily delayed
effects of cost cuts the positive income for the year as stated at
the beginning of the year is expected to be missed.
Additional actions for cost reduction and efficiency increase will be
worked out by the Board of directors soon. Increase of turnover is
expected in 2006 based on launches of new products.
The 3rd quarter report will be introduced November 14th, 2005, as
planned.
Board of Directors
WORLD OF MEDICINE and its technologies are paving the way for
innovative procedures in Minimally Invasive Surgery - or MIS® for
short. WORLD OF MEDICINE markets the products from its core business,
MIS®, through major medical technology firms and established
distributors. WORLD OF MEDICINE exports more than 60 % of its
products, and in the future will also profit from the strong growth
markets outside of Europe. More than 40 % of sales are conducted in
the U.S., the world’s largest medical technology market. In addition
to this, WORLD OF MEDICINE has made well-timed investments in the new
markets opening in Asia, especially China. WORLD OF MEDICINE’s 30
years of experience in MIS® is substantiated by the 50 % global
market share it holds in its core business, Flow&FluidWORLD®, its
long standing relationships with more than 200 business partners,
over 35 FDA approvals, more than 50 patents and the high quality
offered by its production facility in Ludwigsstadt, Germany. The
Stock Of WORLD OF MEDICINE® (ISIN DE 0006637390) is listed in the
Prime Standard in the Frankfurt stock exchange and in the German
Entrepreneurial Index (GEX).
end of announcement                               euro adhoc 21.10.2005 18:12:11

Further inquiry note:

Verena Zahn
Tel.: +49 (0)30 3998155 642
verena.zahn@womcorp.com

Branche: Pharmaceuticals
ISIN: DE0006637390
WKN: 663739
Index: Prime Standard, CDAX, Prime All Share, Technologie All Share
Börsen: Frankfurter Wertpapierbörse / regulated dealing
Berliner Wertpapierbörse / free trade
Hamburger Wertpapierbörse / free trade
Baden-Württembergische Wertpapierbörse / free trade
Börse Düsseldorf / free trade
Bayerische Börse / free trade
Bremer Wertpapierbörse (BWB) / free trade

Plus de actualités: W.O.M. World of Medicine AG
Plus de actualités: W.O.M. World of Medicine AG